Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies

Abstract

Endometrial cancer (EC) is the sixth most prevalent type of cancer among women. Kinases, enzymes mediating the transfer of adenosine triphosphate (ATP) in several signaling pathways, play a significant role in carcinogenesis and cancer cells’ survival and proliferation. Cyclin-dependent kinases (CDKs) are involved in EC pathogenesis; therefore, CDK inhibitors (CDKin) have a noteworthy therapeutic potential in this type of cancer, particularly in EC type 1. Natural compounds have been used for decades in the treatment of cancer serving as a source of anticancer bioactive molecules. Many phenolic and non-phenolic natural compounds covering flavonoids, stilbenoids, coumarins, biphenyl compounds, alkaloids, glycosides, terpenes, and terpenoids have shown moderate to high effectiveness against CDKin-mediated carcinogenic signaling pathways (PI3K, ERK1/2, Akt, ATM, mTOR, TP53). Pharmaceutical regimens based on two natural compounds, trabectedin and ixabepilone, have been investigated in humans showing short and midterm efficacy as second-line treatments in phase II clinical trials. The purpose of this review is twofold: the authors first provide an overview of the involvement of kinases and kinase inhibitors in the pathogenesis and treatment of EC and then discuss the existing evidence about natural products’ derived kinase inhibitors in the management of the disease and outline relevant future research.

Targeting Streptomyces-Derived Streptenol Derivatives against Gynecological Cancer Target PIK3CA: An In Silico Approach

“…Parameters set for 50 trajectory frames within the time span of 10 ns. Distance restraints with global weight of 1.0, and Poisson-Boltzmann/generalized born (PB/GB) molecular mechanics were considered for conformational stability of the PIK3CA-streptenol derivative complex system [ 33 , 34 ].…”

The International Natural Product Sciences Taskforce (INPST) and the power of Twitter networking exemplified through #INPST hashtag analysis

“…Chemical modification of natural product molecules has also yielded multiple clinically relevant drugs such as caspofungin (Walsh et al, 2004), artemether (Hien et al, 1996), or etoposide (Cragg and Pezzuto, 2016;O'Dwyer et al, 1985). As a reflection of the high significance of natural products for the discovery and development of new pharmaceuticals, a high number of natural products or their derivatives are currently in clinical trials for a range of diverse diseases (Ahmad et al, 2021;Lima et al, 2021;Nile and Kai, 2020;Singla et al, 2022aSingla et al, , 2022b. Moreover, multi-component natural product mixtures are also studied to explore their therapeutic potential and used clinically (Wink, 2015).…”

The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research

“…For example, paclitaxel, camptothecin, homoharringtonine, ginsenoside Rg3, etc. In recent years, with the deepening of understanding and attention to natural products, many new opportunities have been brought to the development of natural anti-tumor molecules ( Singla et al, 2021a ; Singla et al, 2021b ; Tan et al, 2021 ; Wang et al, 2021 ; Singla et al, 2022 ).…”